Identification of aminosulfonylarylisoxazole as microRNA-31 regulators

PLoS One. 2017 Aug 4;12(8):e0182331. doi: 10.1371/journal.pone.0182331. eCollection 2017.

Abstract

The discovery of small-molecule regulators of microRNAs remains challenging, but a few have been reported. Herein, we describe small-molecule inhibitors of miR-31, a tumor-associated microRNA (miRNA), identified by high-throughput screening using a cell-based reporter assay. Aminosulfonylarylisoxazole compounds exhibited higher specificity for miR-31 than for six other miRNAs, i.e., miR-15a, miR-16, miR-21, miR-92a-1, miR-146a, and miR-155, and increased the expression of miR-31 target genes. The down-regulation of mature miR-31 was observed, while its precursor form increased following treatment with the compounds. Thus, the compounds may target the processing of pre-miR-31 into mature miR-31 and thereby inhibit the production of mature miR-31.

MeSH terms

  • Biomimetic Materials / pharmacology
  • Drug Evaluation, Preclinical
  • HEK293 Cells
  • Humans
  • Isoxazoles / antagonists & inhibitors
  • Isoxazoles / pharmacology*
  • MCF-7 Cells
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism*
  • RNA Precursors / genetics
  • RNA Precursors / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Up-Regulation / drug effects
  • Up-Regulation / genetics

Substances

  • Isoxazoles
  • MIRN31 microRNA, human
  • MicroRNAs
  • RNA Precursors
  • RNA, Messenger

Grants and funding

This work was supported by the Public welfare Welfare & Safety research program (2010-0020842), the Bio & Medical Technology Development Program (NRF-2012M3A9C7050137) and Advanced Research Center Program (2015R1A5A1008958) through the National Research Foundation of Korea funded by the Korean government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.